These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10391)

  • 21. Inter-species comparison of microsomal reductive transformation of biologically active benfluron N-oxide.
    Skálová L; Nobilis M; Szotáková B; Wsól V; Kvasnicková E
    Drug Metabol Drug Interact; 1998; 14(4):235-50. PubMed ID: 10694931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PREGANGLIONIC AND POSTGANGLIONIC STIMULATION OF THE GUINEA-PIG ISOLATED VAS DEFERENS PREPARATION.
    BIRMINGHAM AT; WILSON AB
    Br J Pharmacol Chemother; 1963 Dec; 21(3):569-80. PubMed ID: 14110756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes.
    Korpi ER; Costakos DT; Wyatt RJ
    Biochem Pharmacol; 1985 Aug; 34(16):2923-7. PubMed ID: 4026878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.
    Lindeke B; Paulsen-Sörman U; Hallström G; Khuthier AH; Cho AK; Kammerer RC
    Drug Metab Dispos; 1982; 10(6):700-5. PubMed ID: 6130927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P-450-dependent nicotine oxidation by liver microsomes of guinea pigs. Immunochemical evidence with antibody against phenobarbital-inducible cytochrome P-450.
    Nakayama H; Nakashima T; Kurogochi Y
    Biochem Pharmacol; 1985 Jul; 34(13):2281-6. PubMed ID: 4015676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.
    Cribb AE; Spielberg SP
    Drug Metab Dispos; 1990; 18(5):784-7. PubMed ID: 1981737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational analysis of 9-substituted adenines in relation to their microsomal N1-oxidation.
    Lam SP; Barlow DJ; Gorrod JW
    J Pharm Pharmacol; 1989 Jun; 41(6):373-8. PubMed ID: 2570831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE INFLUENCE OF CENTRALLY ACTING CHOLINOLYTIC DRUGS ON BRAIN ACETYLCHOLINE LEVELS.
    GIARMAN NJ; PEPEU G
    Br J Pharmacol Chemother; 1964 Aug; 23(1):123-30. PubMed ID: 14208189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The selectivity of the (-)-and (+)-forms of hyoscine methiodide and of hyoscyamine camphorsulphonate for muscarinic (M2) receptors.
    Barlow RB; Dawson S
    Br J Pharmacol; 1986 Oct; 89(2):439-44. PubMed ID: 3779219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Hydroxylation of 2-aminofluorene in the guinea pig and by guinea pig liver microsomes in vitro.
    Kiese M; Renner G; Wiedemann I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 252(5):418-23. PubMed ID: 4222798
    [No Abstract]   [Full Text] [Related]  

  • 32. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene.
    Kadlubar FF; Miller JA; Miller EC
    Cancer Res; 1976 Mar; 36(3):1196-1206. PubMed ID: 814998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox cycle of stable mixed nitroxides formed from carcinogenic aromatic amines.
    Stier A; Clauss R; Lücke A; Reitz I
    Xenobiotica; 1980; 10(7-8):661-73. PubMed ID: 6255685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsomal N- and C-oxidation of 4-substituted N-benzylanilines.
    Gorrod JW; Gooderham NJ
    Xenobiotica; 1985 Dec; 15(12):1021-31. PubMed ID: 3841437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa.
    Ueng YF; Yu HJ; Lee CH; Peng C; Jan WC; Ho LK; Chen CF; Don MJ
    J Chromatogr A; 2005 May; 1076(1-2):103-9. PubMed ID: 15974075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes.
    Clement B; Behrens D; Möller W; Cashman JR
    Chem Res Toxicol; 2000 Oct; 13(10):1037-45. PubMed ID: 11080052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkaloid biogenesis. III. The production of biosynthetic radioactive hyoscine and meteloidine.
    EVANS WC; PARTRIDGE MW
    J Pharm Pharmacol; 1954 Oct; 6(10):702-6. PubMed ID: 13212655
    [No Abstract]   [Full Text] [Related]  

  • 38. Microsomal metabolism of pyrrolizidine alkaloids: N-oxidation of seneciphylline and senecionine.
    Ramsdell HS; Buhler DR
    Toxicol Lett; 1987 Aug; 37(3):241-9. PubMed ID: 3617098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of oxidation of amphetamine enantiomorphs by liver microsomal preparations from different species.
    Beckett AH; Al-Sarraj S
    J Pharm Pharmacol; 1972 Feb; 24(2):174-6. PubMed ID: 4401980
    [No Abstract]   [Full Text] [Related]  

  • 40. Microsomal metabolism of arylamides by the rat and guinea pig--II. Oxidation of 3-fluorenylacetamide at carbon atom 9. Formation of 3-acetamido-9-fluorenone.
    Kaplan E; Gutmann HR
    Biochem Pharmacol; 1979 May; 28(10):1609-14. PubMed ID: 38792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.